We are live on ! Find out more
PM

Penbrook Management Portfolio holdings

AUM $169M Turnover 8.49%
1-Year Est. Return 32.52%
This Fund
S&P 500
This Quarter Est. Return
+12.52%
1 Year Est. Return
+32.52%
3 Year Est. Return
+106.62%
5 Year Est. Return
+155.24%
10 Year Est. Return
–
AUM
$117M
AUM Growth
+$1.13M
Cap. Flow
-$8.43M
Cap. Flow %
-7.18%
Top 10 Hldgs %
47.01%
Holding
100
New
1
Increased
4
Reduced
49
Closed
5
Avg Time Held
5.2 years
Top 10 Avg Time Held
3.6 years
Top 20 Avg Time Held
3 years

Top Buys

Rank Stock Value
1
RRC icon
Range Resources
RRC
+$539K
2
EGIO icon
Edgio, Inc. Common Stock
EGIO
+$356K
3
VET icon
Vermilion Energy
VET
+$252K
4
VRN icon
Veren
VRN
+$228K
5
CVS icon
CVS Health
CVS
+$33.8K

Top Sells

Rank Stock Value
1
NVO icon
Novo Nordisk
NVO
+$1.3M
2
AAPL icon
Apple
AAPL
+$829K
3
MSFT icon
Microsoft
MSFT
+$766K
4
CNX icon
CNX Resources
CNX
+$559K
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$523K

Sector Composition

Rank Sector Weight
1 Healthcare 25.5%
2 Technology 22.02%
3 Energy 16.21%
4 Financials 10.62%
5 Industrials 8.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
QQQ icon
51
Invesco QQQ Trust
QQQ
$475B
$620K 0.53%
2,330
-90
-4% -$24.9K
2018 Q3
17 quarters
INVE icon
52
INVE Technologies, Inc. Common Stock
INVE
$53.8M
$596K 0.51%
82,377
– –
2019 Q3
13 quarters
IBM icon
53
IBM
IBM
$219B
$592K 0.5%
4,200
– –
2022 Q1
3 quarters
SHEL icon
54
Shell
SHEL
$303B
$575K 0.49%
10,100
-2,000
-17% -$110K
2022 Q1
3 quarters
CYRX icon
55
CryoPort
CYRX
$853M
$562K 0.48%
32,415
– –
2018 Q1
19 quarters
CVE icon
56
Cenovus Energy
CVE
$60.7B
$559K 0.48%
28,800
– –
2022 Q1
3 quarters
EMR icon
57
Emerson Electric
EMR
$90.1B
$557K 0.47%
5,800
– –
2014 Q1
35 quarters
FAF icon
58
First American
FAF
$6.63B
$542K 0.46%
10,350
– –
2013 Q4
36 quarters
PIM icon
59
Franklin Master Intermediate Income Trust
PIM
$146M
$534K 0.46%
166,963
-14,414
-8% -$47.4K
2013 Q4
36 quarters
EAF icon
60
GrafTech
EAF
$185M
$528K 0.45%
11,090
-330
-3% -$16K
2018 Q3
17 quarters
IBB icon
61
iShares Biotechnology ETF
IBB
$10.3B
$524K 0.45%
3,990
-30
-0.7% -$3.88K
2016 Q2
26 quarters
BBSI icon
62
Barrett Business Services
BBSI
$789M
$513K 0.44%
22,000
– –
2015 Q4
28 quarters
NVS icon
63
Novartis
NVS
$286B
$495K 0.42%
5,460
-1,000
-15% -$84.2K
2013 Q4
36 quarters
RRC icon
64
Range Resources
RRC
$10.1B
$493K 0.42%
+19,700
New +$539K
2022 Q4
0 quarters
BDX icon
65
Becton Dickinson
BDX
$52.2B
$481K 0.41%
1,893
– –
2013 Q4
36 quarters
EGIO icon
66
DELISTED
Edgio, Inc. Common Stock
EGIO
$470K 0.4%
10,397
+4,618
+80% +$356K
2022 Q2
2 quarters
MRK icon
67
Merck
MRK
$360B
$467K 0.4%
4,206
-500
-11% -$51.1K
2022 Q1
3 quarters
FISV icon
68
Fiserv Inc
FISV
$25.3B
$455K 0.39%
4,500
– –
2013 Q4
36 quarters
BNED icon
69
Barnes & Noble Education
BNED
$449M
$425K 0.36%
2,427
-217
-8% -$51.7K
2021 Q1
7 quarters
DMLP icon
70
Dorchester Minerals
DMLP
$1.49B
$419K 0.36%
14,000
– –
2022 Q2
2 quarters
KOPN icon
71
Kopin
KOPN
$594M
$393K 0.34%
317,200
-250
-0.1% -$309
2016 Q2
26 quarters
COP icon
72
ConocoPhillips
COP
$176B
$368K 0.31%
3,120
-66
-2% -$8.02K
2021 Q1
7 quarters
LINC icon
73
Lincoln Educational Services
LINC
$705M
$361K 0.31%
62,305
– –
2022 Q1
3 quarters
TBIO icon
74
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$323K 0.28%
14,936
– –
2022 Q1
3 quarters
F icon
75
Ford
F
$49.6B
$316K 0.27%
27,175
-2,000
-7% -$25.7K
2020 Q3
9 quarters
1 2
3
4

Similar funds

ACA
Arsenal Capital Advisors Conshohocken, Pennsylvania $169M AUM
CCM
Collar Capital Management Appleton, Wisconsin $170M AUM 76.01% 1-Year Est. Return
CIA
Christian Investment Advisors New Braunfels, Texas $170M AUM 13.8% 1-Year Est. Return
EG
Ellerson Group Annapolis, Maryland $169M AUM 34.68% 1-Year Est. Return
ANHIM
Alan N. Hoffman Investment Management Wellesley Hills, Massachusetts $169M AUM 26.45% 1-Year Est. Return
WS
Wilian Securities Vadnais Heights, Minnesota $169M AUM
CBOR
Community Bank of Raymore Raymore, Missouri $170M AUM 32.14% 1-Year Est. Return
NWMG
Nicholson Wealth Management Group Charlestown, South Carolina $170M AUM 10.45% 1-Year Est. Return

Penbrook Management's Q4 2022 Portfolio in Review

As of Q4 2022, Penbrook Management held 100 positions worth $117M, up 0.97% from $116M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Penbrook Management withdrew a net $8.43M in Q4 2022, closing 5 positions and reducing 49 holdings. Its most notable exit was CNX Resources, an estimated $559K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 22% a quarter earlier, followed by Technology and Energy.

Against the trend, Penbrook Management opened a new position in Range Resources worth $493K.

  • Penbrook Management's largest Q4 2022 buy was Range Resources: 19,700 shares worth $493K.
  • Penbrook Management added most to Edgio, Inc. Common Stock in Q4 2022, an estimated $356K increase.
  • Penbrook Management's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $1.3M.
  • Penbrook Management fully exited CNX Resources in Q4 2022, selling an estimated $559K.
  • Penbrook Management's ten largest holdings make up 47% of its $117M portfolio in Q4 2022.
  • Penbrook Management opened 1 new position and closed 5 in Q4 2022.
  • Penbrook Management's portfolio value rose 0.97% quarter-over-quarter to $117M.

Based on Penbrook Management's 13F filing for Q4 2022, filed 24 Jan 2023.